Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor
A grieving woman looks at an empty chair

Life Health > Life Insurance

What Life Insurers Are Saying About Death Now

X
Your article was successfully shared with the contacts you provided.

The number of U.S. deaths was lower in the fourth quarter of 2022 than in the fourth quarter of 2021, when the COVID-19 omicron variant surge was rolling in, according to executives from Equitable, Lincoln Financial, Global Life and other life insurers.

But total excess mortality from all causes is still noticeably higher than it used to be before the COVID-19 pandemic started, executives said.

What It Means

Predicting how long clients will live is more difficult now than it was five years ago.

Life insurers emphasized that they can handle the new normal by increasing prices and taking other steps to manage their claim risk.

Your own clients still need protection against longevity risk, but they also need to pay attention to mortality risk.

The Calls

The executives have been talking about mortality over the past two weeks, during conference calls their companies have been holding with securities analysts to discuss earnings for the fourth quarter of 2022. The companies stream the calls live online and post recordings in the investor relations sections on their websites.

What the Executives Are Saying

Some life insurers have now tilted away from the individual life market. When they talk about mortality, they’re thinking of mortality at employers’ group life plans.

Some other life insurers continue to offer individual life, and executives at those companies might be thinking of the kinds of people who dominate the typical life insurance agent’s or financial advisor’s client list.

Reinsurance Group of America represents another type of company, a life reinsurer, essentially an insurance company for life insurance companies. It helps the “direct writers” manage their own exposure to all types of mortality risk.

Here’s a look at what executives at the group life issuers, the individual life issuers and RGA are saying about death, drawn from the earnings call recordings.

Group Life Players

Dan Fishbein, president of Sun Life Financial’s Sun Life Financial U.S. unit: “In the U.S., our mortality moderated significantly, still elevated, but moderated significantly, throughout the year, and especially in certainly in the fourth quarter.”

Chris Swift, CEO of Hartford Financial: “Turning to group benefits, the core earnings margin of 8.3% for the quarter and 6.5% for the full year represents significant increases from last year as excess mortality has materially declined.

“With COVID shifting from pandemic, to endemic state, excess mortality losses are expected to improve versus 2022. However, we expect mortality trends will settle above pre-pandemic levels and we are pricing business accordingly.”

Ramy Tadros, president of MetLife’s U.S. business: “With respect to COVID, we see continued reduction in the number of deaths below 65, which also reduces the severity of any potential impacts from COVID.

“But, overall, you really should think about this moving to an endemic environment, one that we’ve priced for.”

Individual Life Players

Randal Freitag, Lincoln Financial´s chief financial officer:  “The life insurance business faced many challenges in 2022 and will continue to be pressured in 2023 by pandemic claims, higher reinsurance costs with some additional spread pressure.”

Robin Raju, Equitable’s CFO: “As you can see, looking back eight quarters, our experience is better than what we assumed in our … reserving.

“In the fourth quarter, we saw elevated claims due to higher frequency, which was likely flu-related, as the fourth quarter saw flu cases peak earlier than historical trends.

“Mortality was $57 million higher than we expected, and which primarily is driven by larger older-age policies.

“Over the long term, our mortality has been better than our GAAP reserve expectations.

“Additionally, preliminary results, year-to-date, show that mortality is performing in line with expectations.”

Tom Kalmbach, Globe Life’s CFO: “Overall, fourth-quarter excess [life insurance] policy obligations were in line with our expectations.

“In the fourth quarter, the company incurred approximately $5 million of COVID life claims related to approximately 31,000 U.S. COVID deaths occurring in the quarter as reported by the CDC and was in line with expectations.

“We also incurred excess deaths, as compared to those expected based on pre-pandemic levels, from non-COVID causes, including deaths due to lung disorders, heart and circulatory issues and neurological disorders.

“We believe the higher level of mortality we have seen is due in large part to the effects of the pandemic. So, as the number of COVID deaths have moderated, so have the number of deaths from other causes.

“In the fourth quarter, the impact of excess non-COVID life policy obligations were generally in line with our expectations at about $6 million…

“Based on the data we currently have available, we estimate incurring approximately $45 million of total excess life policy obligations from both COVID and non-COVID claims in 2023. We estimate that the total reported U.S. deaths from COVID will be approximately 105,000 at the midpoint of our guidance.”

RGA

Todd Larson, RGA’s chief financial officer: “The U.S. and Latin America traditional [life reinsurance] segment results reflected both unfavorable individual mortality experience and COVID-19 claims that totaled approximately $48 million. We believe some of the excess mortality relates to the early flu season.”

Jonathan Porter, RGA’s chief risk officer: “Aggregate non-COVID-19 underwriting experience was modestly unfavorable in the quarter. We continue to benefit from globally diversified book of risks, as higher claims in some markets were in large part offset by favorable underwriting experience in others. Total COVID-19 impacts continue to remain moderate, totaling $70 million pretax across all segments.

“Starting first with U.S. individual mortality, we experienced elevated non-COVID-19 claim costs due to higher claims frequency. Large claim experience was in line with our expectations after two very favorable quarters in Q2 and Q3. Our higher frequency of claims is directionally consistent with the excess levels of U.S. general population mortality, as reported by the [U.S. Centers for Disease Control and Prevention].

“Non-COVID-19 population deaths continue to remain elevated, which was compounded by the first material influenza season since the start of the pandemic. Although total flu cases and estimated mortality appear to be in line with an average pre-pandemic flu season, influenza cases peaked about eight to 10 weeks earlier than historic norms, which we believe shifted the majority of deaths into the fourth quarter.

“U.S. general population data continues to show COVID-19 deaths are primarily at ages above 65, where there is less life insurance exposure.”

(Image: Adobe Stock)


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.